United States
CaliforniaLead compliant global promotional strategy and launch readiness for Kyverna Therapeutics’ autoimmune cell therapies. Build omnichannel programs, high-performing teams, and effective agency partnerships.
Lead global safety and pharmacovigilance strategy for Kyverna Therapeutics’ autoimmune cell therapy pipeline. Oversee signal detection, risk management, regulatory compliance, and clinical safety activities.
Lead commercialization and launch strategy for Kyverna Therapeutics’ CAR-T portfolio in autoimmune diseases. Build the marketing organization and direct lifecycle expansion across multiple indications.
Contract role focused on pharmacovigilance documentation for Kyverna Therapeutics’ autoimmune cell therapies. The work includes FDA responses, safety assessments, advisory committee materials, and related regulatory documents.
